Plain-English translation of NCT06123026 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This trial is testing whether a medication called can help reduce uncomfortable breast symptoms—like engorgement and lactation—that can happen after a second trimester pregnancy loss. After your procedure, you'll receive either the medication or a placebo (an inactive pill that looks identical), and researchers will track your breast symptoms over time to see if the medication makes a meaningful difference.
After a second trimester pregnancy loss, the body naturally begins to prepare for lactation, which can cause breast pain, swelling, and other uncomfortable symptoms. This trial is trying to find out whether this medication can safely and effectively reduce these symptoms and improve comfort during an already difficult time.
After your procedure for pregnancy loss, you will take a single tablet—either the medication or a placebo—right away. You'll then be monitored over time (through follow-up visits or contacts) as researchers track how your breast symptoms change. Your role is simply to take the tablet as instructed and report on your symptoms at scheduled check-ins so the research team can compare how the two groups respond.
AI-generated summary from trial data · Oct 12, 2026 · Not medical advice
United States